Oramaax Dental Products, Inc. – Trademark Portfolio
Entity Type: 03
Oramaax Dental Products, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include ORAMAAX and FLOSSCARD. The owner is based in Rockville Centre, NY.
48 Merrick Road
Rockville Centre, NY 115704708
Showing of trademarks Trademarks
Trademark Classifications
Oramaax Dental Products, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Oramaax Dental Products, Inc. have?
Oramaax Dental Products, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 11 registered, 3 abandoned, 1 cancelled.
What trademark classes does Oramaax Dental Products, Inc. file in?
Oramaax Dental Products, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are Oramaax Dental Products, Inc.'s most well-known trademarks?
Oramaax Dental Products, Inc.'s registered trademark portfolio includes well-known marks such as ORAMAAX and FLOSSCARD. These are among 11 currently registered trademarks in the portfolio.
What is Oramaax Dental Products, Inc.'s trademark registration success rate?
Oramaax Dental Products, Inc. has a 73% trademark registration rate, with 11 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.